Chd2 interacts with H3.3 to determine myogenic cell fate
about
CHD1 and CHD2 are positive regulators of HIV-1 gene expressionChromodomain helicase DNA-binding proteins in stem cells and human developmental diseasesDynamics of histone variant H3.3 and its coregulation with H2A.Z at enhancers and promotersStructure and function of human histone H3.Y nucleosomeConcise Review: Epigenetic Regulation of Myogenesis in Health and DiseaseRegulation of Muscle Stem Cell Functions: A Focus on the p38 MAPK Signaling PathwayHistone H3.3 maintains genome integrity during mammalian developmentCdt1-binding protein GRWD1 is a novel histone-binding protein that facilitates MCM loading through its influence on chromatin architectureTissue-specific expression of histone H3 variants diversified after species separationSingle cell analysis of RNA-mediated histone H3.3 recruitment to a cytomegalovirus promoter-regulated transcription site.A co-localization model of paired ChIP-seq data using a large ENCODE data set enables comparison of multiple samples.Epigenome Maintenance in Response to DNA DamageHuman CHD2 is a chromatin assembly ATPase regulated by its chromo- and DNA-binding domainsArchitects of the genome: CHD dysfunction in cancer, developmental disorders and neurological syndromesThe Drosophila melanogaster CHD1 chromatin remodeling factor modulates global chromosome structure and counteracts HP1a and H3K9me2.Spatial re-organization of myogenic regulatory sequences temporally controls gene expressioniTRAQ-based quantitative proteomic analysis reveals the distinct early embryo myofiber type characteristics involved in landrace and miniature pigGenome-Wide Mapping and Interrogation of the Nmp4 Antianabolic Bone Axis.Exploration of nucleosome positioning patterns in transcription factor function.Mechanisms of epigenetic deregulation in lymphoid neoplasms.The Scaffold attachment factor b1 (Safb1) regulates myogenic differentiation by facilitating the transition of myogenic gene chromatin from a repressed to an activated state.WHSC1 links transcription elongation to HIRA-mediated histone H3.3 depositionDifferential regulation of the histone chaperone HIRA during muscle cell differentiation by a phosphorylation switch.Myogenic differentiation triggers PML nuclear body loss and DAXX relocalization to chromocentres.Epigenetic Control of B Cell Development and B-Cell-Related Immune Disorders.PARP1 Links CHD2-Mediated Chromatin Expansion and H3.3 Deposition to DNA Repair by Non-homologous End-Joining.Histone Variant H3.3: A versatile H3 variant in health and in disease.Expression of Non-acetylatable H2A.Z in Myoblast Cells Blocks Myoblast Differentiation through Disruption of MyoD Expression.Incorporation of histone H3.1 suppresses the lineage potential of skeletal muscle.The Histone Variant H3.3 in Transcriptional Regulation and Human Disease.Chd5 Regulates MuERV-L/MERVL Expression in Mouse Embryonic Stem Cells Via H3K27me3 Modification and Histone H3.1/H3.2.CHD1 regulates cell fate determination by activation of differentiation-induced genes.Chd2 regulates chromatin for proper gene expression toward differentiation in mouse embryonic stem cellsTranscription-coupled recruitment of human CHD1 and CHD2 influences chromatin accessibility and histone H3 and H3.3 occupancy at active chromatin regionsThe PPARγ locus makes long-range chromatin interactions with selected tissue-specific gene loci during adipocyte differentiation in a protein kinase A dependent mannerThe requirement of Mettl3-promoted MyoD mRNA maintenance in proliferative myoblasts for skeletal muscle differentiation.Histone H3.5 forms an unstable nucleosome and accumulates around transcription start sites in human testis.Temporal regulation of chromatin during myoblast differentiation.Regulatory networks specifying cortical interneurons from human embryonic stem cells reveal roles for CHD2 in interneuron development.Histone H3.3 sub-variant H3mm7 is required for normal skeletal muscle regeneration.
P2860
Q24305354-6BCFF9D7-75EA-4F6E-951B-EED3C833236BQ26822979-0F0A3E09-AE4A-4EBD-A794-AAB836FF8879Q26851348-78DD34EF-6886-47B7-8460-2F98802C6A94Q27704313-91C72B54-45CC-4844-8E37-C8FCDAE4E91CQ28072184-333E8567-D88C-49F7-8F78-4F08BBBC1663Q28078887-AC6977A4-2A0B-4539-AAE3-2827AAE86450Q28264875-7AE4A6A6-B28E-47E5-8A35-A99851168B94Q28596608-63D48DD5-E26B-456D-ADAB-F28FF2CD6770Q28607519-F81E3B0C-F73A-482D-8B3A-57A6DB7F809FQ30541321-934CA7A0-732B-4D28-BA77-982F7E5D47BFQ30576103-46A0FA50-5252-4CCF-8101-30A8F3875F40Q33811644-14973424-9B4D-4FFD-886D-69390B15592FQ34447144-9DB9E4DB-764E-49B1-B9C0-0F63E574124EQ34520690-103832AD-E372-4F91-A940-E82FC5DFE878Q34637838-244C5C6B-CEB6-4A8D-9F87-EEAEAA1AF0EFQ35131082-FC73CC1D-5FDF-4DF2-A756-F61168EEB76DQ35934436-CE54EEC4-C359-4837-8600-B2876A6A7AD0Q36004112-34DF2B93-0C6C-4EAD-99B0-9A98DFE028C4Q36500962-03050C84-5132-4891-AED1-6C82DAC5B852Q36873265-F0A79F51-722D-49FA-A38D-B957C9449734Q36909803-EBE97E77-51D9-4278-A51E-D74495A9250EQ37163743-F1C5F851-FCAD-40B7-A95E-9B1224C50012Q37223761-E386E0D3-8CC2-4306-BCE6-6CA97A48ED48Q37745457-FF6EF41E-CD41-4378-99B0-1D17F7E5D16CQ38525405-CF5AA494-5BF3-4A40-8DF5-4C679F69AF97Q38655716-9C9E23D3-57D1-4EF1-A44B-73A97ADDFA3BQ38716435-F253924D-567C-41A8-9819-56E3C6D00197Q38891308-0D09C5D5-A185-4D64-8788-9711FE06CBDEQ38925516-65ACEEE6-A2C2-41DE-B034-0B38510706E8Q39022741-1D98D73D-C5AF-4685-B284-021DABFEDB9BQ41374920-02925537-8C75-4338-BE6B-558EBBC9A2CDQ41510943-B8398412-68DD-4D09-A357-715365AF75BDQ41629015-3292B187-93AA-42F0-84D5-C81187E63276Q41814157-A38B7F42-D496-4996-984C-78283E4FB5B4Q41880401-8E0A3E4D-C188-464C-A596-4C20AF67CD45Q42193999-2DCCC893-FB27-4A5E-9C53-EB58BDAD0B05Q42684221-3244F144-EE78-4829-9A1A-435D00818530Q47288294-86F1A9D5-91A2-4765-AD65-B0E7F76D8BB9Q47304787-249F9EDF-45FE-4454-AF40-A6F8C84DCE8BQ52593139-4C99F646-9F0C-477C-BA29-C656E309B3C0
P2860
Chd2 interacts with H3.3 to determine myogenic cell fate
description
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2012
@ast
im Juni 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2012/06/29)
@sk
vědecký článek publikovaný v roce 2012
@cs
wetenschappelijk artikel (gepubliceerd op 2012/06/29)
@nl
наукова стаття, опублікована в червні 2012
@uk
مقالة علمية (نشرت في 29-6-2012)
@ar
name
Chd2 interacts with H3.3 to determine myogenic cell fate
@ast
Chd2 interacts with H3.3 to determine myogenic cell fate
@en
Chd2 interacts with H3.3 to determine myogenic cell fate
@nl
type
label
Chd2 interacts with H3.3 to determine myogenic cell fate
@ast
Chd2 interacts with H3.3 to determine myogenic cell fate
@en
Chd2 interacts with H3.3 to determine myogenic cell fate
@nl
prefLabel
Chd2 interacts with H3.3 to determine myogenic cell fate
@ast
Chd2 interacts with H3.3 to determine myogenic cell fate
@en
Chd2 interacts with H3.3 to determine myogenic cell fate
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Chd2 interacts with H3.3 to determine myogenic cell fate
@en
P2093
Akihito Harada
Anthony N. Imbalzano
Daijiro Konno
Hirokazu Saiwai
Hiromi Kumamaru
Jun Odawara
Koichi Akashi
Saori Yoshimura
Taro Tachibana
Tomohiko Yoshimi
P2860
P304
P3181
P356
10.1038/EMBOJ.2012.136
P407
P577
2012-06-29T00:00:00Z